Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Coya Therapeutics, Inc. - Common Stock (NQ:COYA)

6.160 +0.070 (+1.15%)
Streaming Delayed Price Updated: 11:23 AM EST, Dec 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Coya Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments ↗
Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available... 
Via Benzinga
News headline image
Coya Therapeutics, Inc. Announces Expansion of Exclusive Worldwide Licensing Agreement with ARScience Biotherapeutics, Inc. for Development and Commercialization of COYA 301, Coya’s Low-Dose Interleukin 2 (IL-2) Product Candidate
From Coya Therapeutics, Inc.
Via Business Wire
News headline image
Coya Therapeutics, Inc. to Present Proof of Concept Clinical Data at Multiple Scientific Conferences Throughout 2023
From Coya Therapeutics, Inc.
Via Business Wire
Coya Therapeutics Stock Down 3.79% Since IPO ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During Friday, 24 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023 ↗
 
Via Benzinga
News headline image
Coya Therapeutics, Inc. Announces Preclinical Data Supporting the Role of Expanded Regulatory T Cells (Tregs) as Potential Disease-Modifying Treatment in an Animal Model of Alzheimer’s Disease (AD)
From Coya Therapeutics, Inc.
Via Business Wire
News headline image
Coya Therapeutics, Inc. Announces Closing of $15.25 Million Initial Public Offering
From Coya Therapeutics, Inc.
Via Business Wire
News headline image
Opening Day: Coya Goes Public In Last Week Of Quiet Year ↗
Coya Therapeutics went public this week, making it the last IPO of the year. Meanwhile, LiveOne announced that Courtside Group filed a registration statement with the SEC for its planned spin-out and... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.